Synaptic vesicle exocytosis: Molecular mechanisms and clinical implications

Neurology

Volumn 80, Issue 21, 2013, Pages 1981-1988

  Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; BOTULINUM TOXIN; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CYSTEINE STRING PROTEIN; CYSTEINE STRING PROTEIN ALPHA; GAMMA SYNUCLEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; MAMMALIAN UNCOORDINATED 13; MAMMALIAN UNCOORDINATED 18; NEUROTOXIN; PROLINE RESIDUE RICH TRANSMEMBRANE 2; PROTEIN; RAB 3 INTERACTING MOLECULE; SNARE PROTEIN; SYNAPSIN; SYNAPTIC VESICLE GLYCOPROTEIN 2; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNAPTOTAGMIN; SYNTAXIN 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALCIUM CHANNELOPATHY; CELL ADHESION; CONVULSION; EPILEPSY; EXOCYTOSIS; MOLECULAR DOCKING; NEUROTRANSMITTER RELEASE; PAROXYSMAL KINESIGENIC DYSKINESIA; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SEIZURE; SIGNAL TRANSDUCTION; SYNAPSE VESICLE;

ANIMALS; CALCIUM SIGNALING; EXOCYTOSIS; HUMANS; NERVOUS SYSTEM DISEASES; PRESYNAPTIC TERMINALS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 84879088320     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318293e3cd     Document Type: Article

References (45)

1. Sudhof TC. The presynaptic active zone. Neuron 2012;75:11-25.
2. Sudhof TC, Rizo J. Synaptic vesicle exocytosis. Cold Spring Harb Perspect Biol 2011;3.
3. Jahn R, Fasshauer D. Molecular machines governing exocytosis of synaptic vesicles. Nature 2012;490:201-207.
4. Gundelfinger ED, Fejtova A. Molecular organization and plasticity of the cytomatrix at the active zone. Curr Opin Neurobiol 2012;22:423-430.
5. Davies JN, Zamponi GW. Old proteins, developing roles: the regulation of calcium channels by synaptic proteins. Channels 2008;2:130-138.
6. Catterall WA, Few AP. Calcium channel regulation and presynaptic plasticity. Neuron 2008;59:882-901.
7. Chang WP, Sudhof TC. SV2 renders primed synaptic vesicles competent for Ca21-induced exocytosis. J Neurosci 2009;29:883-897.
8. Nowack A, Yao J, Custer KL, Bajjalieh SM. SV2 regulates neurotransmitter release via multiple mechanisms. Am J Physiol Cell Physiol 2010;299:C960-C967.
9. Nowack A, Malarkey EB, Yao J, Bleckert A, Hill J, Bajjalieh SM. Levetiracetam reverses synaptic deficits produced by overexpression of SV2A. PLoS One 2011;6:e29560.
10. Bauer CS, Tran-Van-Minh A, Kadurin I, Dolphin AC. A new look at calcium channel alpha2delta subunits. Curr Opin Neurobiol 2010;20:563-571.
11. Missler M, Fernandez-Chacon R, Sudhof TC. The making of neurexins. J Neurochem 1998;71:1339-1347.
12. Katz B, Miledi R. Further study of the role of calcium in synaptic transmission. J Physiol 1970;207:789-801.
13. Zucker RS, Regehr WG. Short-term synaptic plasticity. Annu Rev Physiol 2002;64:355-405.
14. Atluri PP, Regehr WG. Determinants of the time course of facilitation at the granule cell to Purkinje cell synapse. J Neurosci 1996;16:5661-5671.
15. Llinas R, Steinberg IZ, Walton K. Relationship between presynaptic calcium current and postsynaptic potential in squid giant synapse. Biophys J 1981;33:323-351.
16. Atluri PP, Regehr WG. Delayed release of neurotransmitter from cerebellar granule cells. J Neurosci 1998;18:8214-8227.
17. Cesca F, Baldelli P, Valtorta F, Benfenati F. The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 2010;91:313-348.
18. Yang Y, Calakos N. Munc13-1 is required for presynaptic long-term potentiation. J Neurosci 2011;31:12053-12057.
19. Tsetsenis T, Younts TJ, Chiu CQ, Kaeser PS, Castillo PE. Sudhof TC. Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning. Proc Natl Acad Sci USA 2011;108:14300-14305.
20. Muller M, Liu KS, Sigrist SJ, Davis GW. RIM controls homeostatic plasticity through modulation of the readilyreleasable vesicle pool. J Neurosci 2012;32:16574-16585.
21. Rummel A. Double receptor anchorage ofbotulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 2013;364:61-90.
22. Yeh FL, Dong M, Yao J, et al. SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog 2010;6:e1001207.
23. Ahnert-Hilger G, Munster-Wandowski A, Holtje M. Synaptic vesicle proteins: targets and routes for botulinum neurotoxins. Curr Top Microbiol Immunol 2013;364:159-177.
24. Restani L, Giribaldi F, Manich M, et al. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog 2012;8:e1003087.
25. Catterall WA, Dib-Hajj S, Meisler MH, Pietrobon D. Inherited neuronal ion channelopathies: new windows on complex neurological diseases. J Neurosci 2008;28:11768-11777.
26. Rajakulendran S, Kaski D, Hanna MG. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol 2012;8:86-96.
27. Pietrobon D. CaV2.1 channelopathies. Pflugers Arch 2010;460:375-393.
28. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calciumchannel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
29. Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997;147:35-42.
30. Burk K, Wick M, Roth G, Decker P, Voltz R. Antineuronal antibodies in sporadic late-onset cerebellar ataxia. J Neurol 2010;257:59-62.
31. Iwanami M, Odaka M, Nakamura T, Hirata K. Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer. Brain Nerve 2009;61:1083-1087.
32. Stelzl U, Worm U, Lalowski M, et al. A human proteinprotein interaction network: a resource for annotating the proteome. Cell 2005;122:957-968.
33. Jarvis SE, Zamponi GW. Masters or slaves? Vesicle release machinery and the regulation of presynaptic calcium channels. Cell Calcium 2005;37:483-488.
34. Cohen-Kutner M, Nachmanni D, Atlas D. CaV2. 1 (P/Q channel) interaction with synaptic proteins is essential for depolarization-evoked release. Channels 2010;4:266-277.
35. Condliffe SB, Corradini I, Pozzi D, Verderio C, Matteoli M. Endogenous SNAP-25 regulates native voltage-gated calcium channels in glutamatergic neurons. J Biol Chem 2010;285:24968-24976.
36. Cloarec R, Bruneau N, Rudolf G, et al. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 2012;79:2097-2103.
37. Lee HY, Huang Y, Bruneau N, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012;1:2-12.
38. de Vries B, Callenbach PM, Kamphorst JT, et al. PRRT2 mutation causes benign familial infantile convulsions. Neurology 2012;79:2154-2155.
39. Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology 2012;79:2115-2121.
40. Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 2012;79:2109-2114.
41. Riant F, Roze E, Barbance C, et al. PRRT2 mutations cause hemiplegic migraine. Neurology 2012;79:2122-2124.
42. Scheffer IE, Grinton BE, Heron SE, et al. PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology 2012;79:2104-2108.
43. Guerrini R, Mink JW. Paroxysmal disorders associated with PRRT2 mutations shake up expectations on ion channel genes. Neurology 2012;79:2086-2088.
44. Corradini I, Donzelli A, Antonucci F, et al. Epileptiform activity and cognitive deficits in SNAP-25 +/- mice are normalized by antiepileptic drugs. Cereb Cortex Epub 2012 Oct. 12.
45. Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 2012;14:38-48.